Advertisement

First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO

First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO

Compass Pathways jumped in its first day of trading on Friday, making it the first psychedelic drug company to go public on a big U.S. exchange.